article · Current Cancer Drug Targets

Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients

Fatma Elgebaly
Reham Abdelkader Elkhouly
Ibrahim Amer
Sherief Abd‐Elsalam
Sabry Abou-Saif
Mahmoud Elkadeem
Mohamed Yousef
Amal Helmy
Taher El-Demerdash

201947 citationsKafr el-Sheikh University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

High sPD-L1 level could be a possible prognostic indicator for a poor outcome in liver cirrhosis and HCC patients. The predictive value of sPD-L1 levels for a successful anti- PD1/PD-L1 therapy should be investigated in the future.

Research topics

Liver Disease Diagnosis and Treatment
Hepatitis B Virus Studies
Hepatocellular Carcinoma Treatment and Prognosis

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2174/1568009619666190718141647

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.